Please assess the completion status of the following clinical trial:

Trial Title: Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects 18-99 years of age~* Presence of an endobronchial mass~* Need for flexible bronchoscopy, with endobronchial biopsies~Exclusion Criteria:~* PCO2 \> 47 mm Hg, and/or long term Oxygen therapy~* Unwillingness to undergo fiberoptic bronchoscopy~* Coagulopathy, defined as a platelets count \< 100.000/mm3, or an INR\> 1.4, or known clinical bleeding disorder~* Therapy with anticoagulant, including Coumadin and Clopidogrel~* Renal dysfunction, defined as a Creatinine \> 2 mg/dl~* Life-threatening arrhythmias, or history of myocardial infarction within 6 months~* Cerebrovascular Accident within the preceding 6 months~* Facial abnormality preventing safe introduction of the bronchoscope~* Uncontrolled hypertension~* Active liver disease~* Pregnancy or Breastfeeding~* Prisoners~* Inability to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Optical Coherence Tomography (Type: None): Examine OCT images and compare them to conventional biopsies in same subject.

Based on this trial design, predict the completion outcome and termination type (if applicable).